文献
J-GLOBAL ID:201202236047248869
整理番号:12A1188475
ムスカリン4(M4)受容体の新しく、選択的で、脳浸透性のpositive allosteric modulatorとしてのN-(4-メトオキシ-7-メチルベンゾ[d]チアゾール-2-yl)イソニコチンアミド,ML293の発見
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
著者 (40件):
SALOVICH James M.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SALOVICH James M.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SALOVICH James M.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
VINSON Paige N.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
VINSON Paige N.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
VINSON Paige N.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
SHEFFLER Douglas J.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SHEFFLER Douglas J.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SHEFFLER Douglas J.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
LAMSAL Atin
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
LAMSAL Atin
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
LAMSAL Atin
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
UTLEY Thomas J.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
UTLEY Thomas J.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
UTLEY Thomas J.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
BLOBAUM Anna L.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
BLOBAUM Anna L.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
BLOBAUM Anna L.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
BRIDGES Thomas M.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
BRIDGES Thomas M.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
BRIDGES Thomas M.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
LE Uyen
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
LE Uyen
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
LE Uyen
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
JONES Carrie K.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
JONES Carrie K.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
JONES Carrie K.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
JONES Carrie K.
(US Dep. of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37232, USA)
,
WOOD Michael R.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
WOOD Michael R.
(Dep. of Chemistry, Vanderbilt Univ., Nashville, TN 37232, USA)
,
WOOD Michael R.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
WOOD Michael R.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
SCOTT DANIELS J.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SCOTT DANIELS J.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
SCOTT DANIELS J.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
JEFFREY CONN P.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
JEFFREY CONN P.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
JEFFREY CONN P.
(Vanderbilt Specialized Chemistry Center for Probe Dev. (MLPCN), Nashville, TN 37232, USA)
,
NISWENDER Colleen M.
(Dep. of Pharmacology, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
,
NISWENDER Colleen M.
(Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Univ. Medical Center, Nashville, TN 37232, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
22
号:
15
ページ:
5084-5088
発行年:
2012年08月01日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)